Finance FDA Reverses Stance on Moderna’s Flu Vaccine Review After Quick Talks The FDA now plans to review Moderna's flu vaccine candidate after rejecting it just a week ago. The… Vincent K · Feb 18, 2026
Finance FDA Rejects Moderna’s Flu Vaccine Review Over Trial Design Moderna's push for its mRNA flu vaccine hit a snag as the FDA refused to review the application.… Vincent K · Feb 10, 2026
Finance Analyst Sees Path Forward After FDA Rejects Aquestive Drug The FDA rejected Aquestive Therapeutics' Anaphylm application due to packaging and use concerns. Leerink analysts see a silver… Lauren Whitmore · Feb 3, 2026